GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $95,000 | +23.4% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $77,000 | -34.7% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $118,000 | +61.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $73,000 | -7.6% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $79,000 | -54.9% | 1,500 | -54.5% | 0.00% | -50.0% |
| Q1 2019 | $175,000 | +316.7% | 3,300 | +200.0% | 0.00% | – |
| Q3 2018 | $42,000 | -16.0% | 1,100 | 0.0% | 0.00% | – |
| Q2 2018 | $50,000 | -5.7% | 1,100 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $53,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |